Actinium Pharmaceuticals, Inc. (ATNM) Share-based Payment Arrangement, Expense USD 2012 - 2022

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Actinium Pharmaceuticals, Inc. quarterly Share-based Payment Arrangement, Expense history and growth rate from 2012 to 2022.
  • Actinium Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2022 was $6 K, a 62.5% decline year-over-year.
  • Actinium Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2022 was $6 K.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly Data (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $6 K $6 K -$10 K -62.5% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q4 2021 $16 K $16 K Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q1 2021 $400 K $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-14
Q1 2020 $400 K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $8 K $8 K -$25 K -75.8% Jan 1, 2019 Dec 31, 2019 10-K 2020-05-08
Q4 2018 $33 K $33 K +$23 K +230% Jan 1, 2018 Dec 31, 2018 10-K 2020-05-08
Q4 2017 $10 K $10 K $0 0% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-15
Q4 2016 $10 K -$2.69 M -$3.39 M -484% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-15
Q4 2016 $10 K $10 K -$3.39 M -99.7% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-15
Q3 2016 $3.4 M $1 M +$200 K +25% Jul 1, 2016 Sep 30, 2016 10-Q 2016-10-28
Q2 2016 $3.2 M $900 K $0 0% Apr 1, 2016 Jun 30, 2016 10-Q 2016-07-29
Q1 2016 $3.2 M $800 K -$200 K -20% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $3.4 M $700 K -$100 K -12.5% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-11
Q4 2015 $3.4 M $3.4 M +$1 M +41.7% Jan 1, 2015 Dec 31, 2015 10-K 2016-03-11
Q3 2015 $3.5 M $800 K +$100 K +14.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-28
Q2 2015 $3.4 M $900 K +$300 K +50% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-29
Q1 2015 $3.1 M $1 M +$700 K +233% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $2.4 M $800 K +$784 K +5019% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-11
Q4 2014 $2.4 M $2.4 M +$2.1 M +700% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-11
Q3 2014 $1.62 M $700 K +$604 K +629% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-30
Q2 2014 $1.01 M $600 K +$506 K +537% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $506 K $300 K +$206 K +218% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $300 K $15.6 K Oct 1, 2013 Dec 31, 2013 10-K 2016-03-11
Q4 2013 $300 K $300 K +$100 K +50% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-11
Q3 2013 $96 K +$23.9 K +33.1% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-31
Q2 2013 $94.2 K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 $94.2 K +$53.8 K +133% Jan 1, 2013 Mar 31, 2013 10-Q 2013-08-13
Q4 2012 $200 K $200 K Jan 1, 2012 Dec 31, 2012 10-K 2014-02-28
Q3 2012 $72.1 K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q1 2012 $40.4 K Jan 1, 2012 Mar 31, 2012 10-Q 2013-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.